CDKN2B and hepatocellular carcinoma: Previous studies have indeed demonstrated the involvement of p19INK4D in proliferative arrest after HDAC1 and HDAC2 inhibition in hepatocellular carcinoma cells [34], as well as the involvement of p15INK4B after treatment of HaCat cells with TSA or NaB [38].